Leapfrog Bio
Founded 2019 · 13 employees on LinkedIn · 1 known investors
Leapfrog Bio is an oncology therapeutics company that uses its Precision PGx Platform to identify and develop targeted cancer treatments, focusing on patients with loss-of-function mutations through synthetic lethality and pharmacogenomic screening.
Founders & leadership
Leapfrog Bio was founded in 2019 by Tomas Babak.
TB
Tomas BabakinFounder and CSO
Investors · 1
Frequently asked questions
- What does Leapfrog Bio do?
- Leapfrog Bio is an oncology therapeutics company that uses its Precision PGx Platform to identify and develop targeted cancer treatments, focusing on patients with loss-of-function mutations through synthetic lethality and pharmacogenomic screening.
- Who founded Leapfrog Bio?
- Leapfrog Bio was founded by Tomas Babak in 2019.
- Who are Leapfrog Bio's investors?
- Leapfrog Bio's investors include Two Bear Capital.